Phase II Study of Ramucirumab and Docetaxel for Previously Treated Non-Small Cell Lung Cancer Patients With Malignant Pleural Effusion: Protocol of PLEURAM Study
Thoracic Cancer - Australia
doi 10.1111/1759-7714.13279
Full Text
Open PDFAbstract
Available in full text
Date
December 18, 2019
Authors
Publisher
Wiley